¿©¼º °íÀ¯ Áúȯ Ä¡·áÁ¦ : °¢Á¾ ±â¼ú°ú ¼¼°è ½ÃÀå
Therapeutics for Women¢¥s Health: Technologies and Global Markets
»óǰÄÚµå : 1691627
¸®¼­Ä¡»ç : BCC Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 159 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,650 £Ü 6,598,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,580 £Ü 7,918,000
PDF (2-5 Users) help
PDF º¸°í¼­¸¦ 2-5¸íÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,696 £Ü 9,502,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,035 £Ü 11,402,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Àü ¼¼°è ¿©¼º °íÀ¯ Áúȯ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð´Â 2024³â 615¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È CAGR 5.7%·Î ¼ºÀåÇÏ¿© 2029³â ¸»¿¡´Â 812¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì ½ÃÀåÀº 2024³â 284¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È 5.6%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2029³â ¸»¿¡´Â 374¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´ ½ÃÀåÀº 2024³â 177¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È CAGR 5.8%·Î ¼ºÀåÇÏ¿© 2029³â ¸»¿¡´Â 235¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ ¿©¼º °íÀ¯ Áúȯ Ä¡·áÁ¦ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±ÔÁ¦ ȯ°æ, ½ÅÈï ±â¼ú ¹× ±â¼ú °³¹ß µ¿Çâ, ½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ½ÃÀå ¿ªÇÐ

Á¦4Àå ½Å±â¼ú

Á¦5Àå ÆÄÀÌÇÁ¶óÀÎ Æò°¡¿Í ºÐ¼®

Á¦6Àå ±ÔÁ¦ ±¸Á¶

Á¦7Àå ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ESG °üÁ¡

Á¦10Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global therapeutics for women’s health technologies market is expected to grow from $61.5 billion in 2024 and is projected to reach $81.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2024 to 2029.

The North American therapeutics for women’s health technologies market is expected to grow from $28.4 billion in 2024 and is projected to reach $37.4 billion by the end of 2029, at a CAGR of 5.6% during the forecast period of 2024 to 2029.

The European therapeutics for women’s health technologies market is expected to grow from $17.7 billion in 2024 and is projected to reach $23.5 billion by the end of 2029, at a CAGR of 5.8% during the forecast period of 2024 to 2029.

Report Scope

This report provides a detailed analysis of the global therapeutics for women's health technologies market, including coverage of market drivers, restraints and opportunities. It also includes analyses of this market's competitive environment and products. The report presents market estimates and forecasts for women's health therapeutics and provides market projections through 2029. For this analysis, the market is segmented by conditions related to women's health, including breast cancer, postmenopausal osteoporosis, menopause, endometriosis and polycystic ovary syndrome (PCOS), and by geographic region. The report provides company profiles of the market's leading players that feature detailed information about each company's business segments, financials, product portfolios and recent developments.

By region, the global therapeutics for women's health technologies market is segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW). The North American region includes the U.S., Canada and Mexico. Europe includes the U.K., Germany, Spain, France, Italy and the Rest of Europe; Asia-Pacific comprises China, Japan, India, Australia, South Korea and the Rest of Asia-Pacific. The rest of the World includes the Middle East and Africa, and South America. In the report's market estimates, 2021 and 2022 serve as historical years, 2023 as the base year, and data forecasts are given through 2029.

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Emerging Technologies

Chapter 5 Pipeline Assessment and Analysis

Chapter 6 Regulatory Structure

Chapter 7 Market Segmentation Analysis

Chapter 8 Competitive Landscape

Chapter 9 ESG Perspective

Chapter 10 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â